Markers of Prognosis and Response to Treatment: Ready for Clinical Use in Oncology? A Biostatistician's Viewpoint - P. Boracchi, E. Biganzoli, 2003
![Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted Therapies – PLOS Currents Evidence on Genomic Tests Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted Therapies – PLOS Currents Evidence on Genomic Tests](https://currents.plos.org/genomictests/files/2014/04/PLoS-EGT-NGS_authors-revisions_April-29-2014_Table-1.png)
Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted Therapies – PLOS Currents Evidence on Genomic Tests
![Frontiers | Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China Frontiers | Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China](https://www.frontiersin.org/files/Articles/509552/fonc-10-00800-HTML/image_m/fonc-10-00800-t001.jpg)